Neurofibromatosis type 2 (NF2) tumours
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Neurofibromatosis type 2 (NF2) tumours. NF2 is a tumour predisposition syndrome. Fully referenced neurology checklist.
Pathology
- NF2 is a tumour predisposition syndrome
- It is defined by vestibular schwannomas
- There is also an association with other tumours
Revised Manchester diagnostic criteria
Locked: subscribe to see this section.
Vestibular schwannomas
Locked: subscribe to see this section.
Non-vestibular schwannomas
Locked: subscribe to see this section.
Meningiomas
Locked: subscribe to see this section.
Other tumours
Locked: subscribe to see this section.
Differential diagnosis
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Ferner RE. The neurofibromatoses. Pract Neurol 2010; 10:82-93.
- Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 2007; 6:340-351.
- Gregory GE, Islim AI, Hannan CJ, et al. The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis. Neurooncol Adv 2023; 5(Suppl 1):i94-i104.
- Gareth D, Evans R. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 2009; 4:16.
- Evans DGR, Salvador H, Chang VY, et al. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. Clin Cancer Res 2017; 23:e54-e61.
- And 6 more. Subscribe to see the full list
